US Bancorp’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.17K | Sell |
441
-93
| -17% | -$1.3K | ﹤0.01% | 3566 |
|
|
2025
Q1 | $7.26K | Sell |
534
-479
| -47% | -$6.51K | ﹤0.01% | 3528 |
|
|
2024
Q4 | $20.6K | Sell |
1,013
-155
| -13% | -$3.16K | ﹤0.01% | 3137 |
|
|
2024
Q3 | $34K | Sell |
1,168
-448
| -28% | -$13.1K | ﹤0.01% | 2912 |
|
|
2024
Q2 | $37.5K | Buy |
1,616
+863
| +115% | +$20K | ﹤0.01% | 2802 |
|
|
2024
Q1 | $15.5K | Buy |
753
+254
| +51% | +$5.21K | ﹤0.01% | 3179 |
|
|
2023
Q4 | $10.7K | Sell |
499
-341
| -41% | -$7.32K | ﹤0.01% | 3297 |
|
|
2023
Q3 | $17.3K | Buy |
840
+255
| +44% | +$5.26K | ﹤0.01% | 2945 |
|
|
2023
Q2 | $17.3K | Sell |
585
-71
| -11% | -$2.1K | ﹤0.01% | 3020 |
|
|
2023
Q1 | $15.1K | Buy |
656
+199
| +44% | +$4.59K | ﹤0.01% | 3112 |
|
|
2022
Q4 | $12.7K | Sell |
457
-46
| -9% | -$1.28K | ﹤0.01% | 3205 |
|
|
2022
Q3 | $15K | Buy |
503
+46
| +10% | +$1.37K | ﹤0.01% | 3162 |
|
|
2022
Q2 | $13K | Sell |
457
-102
| -18% | -$2.9K | ﹤0.01% | 3250 |
|
|
2022
Q1 | $18K | Buy |
559
+115
| +26% | +$3.7K | ﹤0.01% | 3113 |
|
|
2021
Q4 | $20K | Buy |
444
+6
| +1% | +$270 | ﹤0.01% | 3091 |
|
|
2021
Q3 | $22K | Sell |
438
-40
| -8% | -$2.01K | ﹤0.01% | 3061 |
|
|
2021
Q2 | $37K | Buy |
478
+12
| +3% | +$929 | ﹤0.01% | 2802 |
|
|
2021
Q1 | $27K | Buy |
466
+71
| +18% | +$4.11K | ﹤0.01% | 2873 |
|
|
2020
Q4 | $33K | Buy |
395
+254
| +180% | +$21.2K | ﹤0.01% | 2669 |
|
|
2020
Q3 | $5K | Buy |
141
+57
| +68% | +$2.02K | ﹤0.01% | 3225 |
|
|
2020
Q2 | $2K | Buy |
+84
| New | +$2K | ﹤0.01% | 3412 |
|